1. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study. Issue 2 (February 2019) Authors: Younes, Anas; Brody, Joshua; Carpio, Cecilia; Lopez-Guillermo, Armando; Ben-Yehuda, Dina; Ferhanoglu, Burhan; Nagler, Arnon; Ozcan, Muhit; Avivi, Irit; Bosch, Francesc; Caballero Barrigón, Maria Dolores; Hellmann, Andrzej; Kuss, Bryone; Ma, David D F; Demirkan, Fatih; Yağci, Münci; Horowitz, Neta... Journal: Lancet Issue: Volume 6:Issue 2(2019) Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗